Mirna Therapeutics

About

Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.

Austin,Texas,United States
11 - 50

Highlights

Details

Last Funding Type: Series D
Last Funding Money Raised: $41.80M
Industries: Biotechnology,Health Care,Therapeutics
Founded date: Jan 1, 2007
Number Of Employee: 11 - 50
Operating Status: Active
Stock Symbol: nasdaq:MIRN
Legal Name: Mirna Therapeutics, Inc.

Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$153.89M

Mirna Therapeutics has raised a total of $153.89M in funding over 2 rounds. Their latest funding was raised on Oct 5, 2015 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 5, 2015	Post-IPO Equity	$16.80M	—	—	—	Detail
Sep 30, 2015	IPO	$44M	—	—	—	Detail
Apr 30, 2015	Series D	$41.80M	11	Baxter Ventures	—	Detail
Oct 24, 2012	Series C	$34.50M	6	Sofinnova Investments	—	Detail
Aug 23, 2011	Series B	$1.50M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

12

Mirna Therapeutics is funded by 12 investors. Baxter Ventures and Celgene are the most recent investors.

Investor Name	Lead Investor	Funding Round
Baxter Ventures	Yes	Series D
Celgene	—	Series D
Correlation Ventures	—	Series D
Eastern Capital	—	Series D
Morningside Group	—	Series D
New Enterprise Associates	—	Series D
OUP (Osage University Partners)	—	Series D
Pfizer Venture Investments	—	Series D
Rock Springs Capital	—	Series D
Sante Ventures	—	Series D